Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Mayo Clin Proc. 2015 Jun;90(6):716–729. doi: 10.1016/j.mayocp.2015.03.016

Figure 1.

Figure 1

Figure 1

Clinical implementation summaries / clinical decision supports for given genotypes of (A) clopidogrel and (B) simvastatin.

The creation of a clinical implementation summary (genotype-specific pharmacogenomic result with clinical decision support), which informs physicians of important pharmacogenomic information, was our measure of the ultimate clinical applicability of a specific drug/variant pair. Each summary contains an interpretation of the evidence, the assigned Level of Evidence rating, and hyperlinks to the primary literature evidence forming the basis for the summary.